UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Therapeutic potential of boron-containing compounds

Future medicinal chemistry, 2009-10, Vol.1 (7), p.1275-1288

2009

Volltextzugriff (PDF)

Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria

Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2431

2020

Volltextzugriff (PDF)

Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase

Bioorganic & medicinal chemistry letters, 2013-10, Vol.23 (20), p.5533-5539

2013

Volltextzugriff (PDF)

Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent

Bioorganic & medicinal chemistry letters, 2022-09, Vol.71, p.128824-128824, Article 128824

2022

Volltextzugriff (PDF)

Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development

Bioorganic & medicinal chemistry letters, 2024-09, Vol.112, p.129941, Article 129941

2024

Volltextzugriff (PDF)

Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent

Bioorganic & medicinal chemistry letters, 2022-09, Vol.72, p.128871-128871, Article 128871

2022

Volltextzugriff (PDF)

Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor

Bioorganic & medicinal chemistry letters, 2024-07, Vol.107, p.129769-129769, Article 129769

2024

Volltextzugriff (PDF)

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Antimicrobial agents and chemotherapy, 2016-10, Vol.60 (10), p.6271-6280

2016

Volltextzugriff (PDF)

Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)

Bioorganic & medicinal chemistry letters, 2022-06, Vol.66, p.128734-128734, Article 128734

2022

Volltextzugriff (PDF)

Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutations

Bioorganic & medicinal chemistry letters, 2022-06, Vol.66, p.128730-128730, Article 128730

2022

Volltextzugriff (PDF)

Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (22), p.127601-127601, Article 127601

2020

Volltextzugriff (PDF)

Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073

Antimicrobial agents and chemotherapy, 2020-09, Vol.64 (10)

2020

Volltextzugriff (PDF)

Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents

Bioorganic & medicinal chemistry letters, 2019-09, Vol.29 (17), p.2511-2515

2019

Volltextzugriff (PDF)

Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice

ACS medicinal chemistry letters, 2016-10, Vol.7 (10), p.896-901

2016

Volltextzugriff (PDF)

Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase

Bioorganic & medicinal chemistry letters, 2014-08, Vol.24 (16), p.3764-3771

2014

Volltextzugriff (PDF)

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

Bioorganic & medicinal chemistry letters, 2011-04, Vol.21 (8), p.2533-2536

2011

Volltextzugriff (PDF)

Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase

Bioorganic & medicinal chemistry letters, 2014-12, Vol.24 (24), p.5683-5687

2014

Volltextzugriff (PDF)

Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase

Bioorganic & medicinal chemistry letters, 2015-01, Vol.25 (1), p.75-82

2015

Volltextzugriff (PDF)

Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone

Bioorganic & medicinal chemistry letters, 2013-02, Vol.23 (4), p.963-966

2013

Volltextzugriff (PDF)

Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants

Journal of medicinal chemistry, 2012-04, Vol.55 (7), p.3021-3026

2012

Volltextzugriff (PDF)

Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis

ACS medicinal chemistry letters, 2015-08, Vol.6 (8), p.913-918

2015

Volltextzugriff (PDF)

Synthesis and biological evaluation of novel pyrrolidine acid analogs as potent dual PPARα/γ agonists

Bioorganic & medicinal chemistry letters, 2015-03, Vol.25 (6), p.1196-1205

2015

Volltextzugriff (PDF)

Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease

Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (24), p.7317-7322

2010

Volltextzugriff (PDF)

Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties

Bioorganic & medicinal chemistry letters, 2011-04, Vol.21 (7), p.2048-2054

2011

Volltextzugriff (PDF)

Synthesis of novel benzoxaborole-containing phenylalanine analogues

Tetrahedron letters, 2011-09, Vol.52 (38), p.4924-4926

2011

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(137)
Tagungsberichte
(2)

Sprache

Englisch
(139)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(79)
Physical Sciences
(50)
Humans
(45)
Chemistry
(44)
Pharmacology & Pharmacy
(41)
Chemistry, Medicinal
(39)
Animals
(34)
Chemistry, Organic
(34)
Biological And Medical Sciences
(31)
Structure-Activity Relationship
(26)
Medical Sciences
(22)
Female
(20)
Pharmacology. Drug Treatments
(18)
Male
(15)
Mutation
(14)
Rats
(13)
Biochemistry & Molecular Biology
(12)
Adult
(11)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Therapeutic potential of boron-containing compounds

Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria

Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase

Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent

Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development

Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent

Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)

Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutations

Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)

Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073

Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents

Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice

Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase

Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase

Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone

Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants

Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis

Synthesis and biological evaluation of novel pyrrolidine acid analogs as potent dual PPARα/γ agonists

Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease

Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties

Synthesis of novel benzoxaborole-containing phenylalanine analogues

Suchergebnisse filtern